These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 16502122)

  • 1. Association between bone mineral density and erythropoiesis in Thai children and adolescents with thalassemia syndromes.
    Mahachoklertwattana P; Pootrakul P; Chuansumrit A; Choubtum L; Sriphrapradang A; Sirisriro R; Rajatanavin R
    J Bone Miner Metab; 2006; 24(2):146-52. PubMed ID: 16502122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density, biochemical and hormonal profiles in suboptimally treated children and adolescents with beta-thalassaemia disease.
    Mahachoklertwattana P; Chuansumrit A; Sirisriro R; Choubtum L; Sriphrapradang A; Rajatanavin R
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):273-9. PubMed ID: 12608931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalassemia bone disease: a 19-year longitudinal analysis.
    Wong P; Fuller PJ; Gillespie MT; Kartsogiannis V; Kerr PG; Doery JC; Paul E; Bowden DK; Strauss BJ; Milat F
    J Bone Miner Res; 2014 Nov; 29(11):2468-73. PubMed ID: 24764138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low bone mineral density in adolescents with beta-thalassemia.
    Vogiatzi MG; Autio KA; Mait JE; Schneider R; Lesser M; Giardina PJ
    Ann N Y Acad Sci; 2005; 1054():462-6. PubMed ID: 16339698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythroid marrow activity and functional anemia in patients with the rare interaction of a single functional a-globin and beta-globin gene.
    Traeger-Synodinos J; Papassotiriou I; Vrettou C; Skarmoutsou C; Stamoulakatou A; Kanavakis E
    Haematologica; 2001 Apr; 86(4):363-7. PubMed ID: 11325640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density in children and young adults with beta-thalassemia trait.
    Mahachoklertwattana P; Chuansumrit A; Choubtum L; Sriphrapradang A; Sirisriro R; Rajatanavin R
    J Pediatr Endocrinol Metab; 2002; 15(9):1531-5. PubMed ID: 12503861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor Activator of Nuclear Factor κ-Β Ligand/Osteoprotegerin Axis in Adults with Hb S/β-Thalassemia and β-Thalassemia Trait.
    Tombak A; Boztepe B; Akbayir S; Dogru G; Sungur MA
    Hemoglobin; 2020 Sep; 44(5):334-337. PubMed ID: 32873083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density in primarily preadolescent children with hemoglobin E/β-thalassemia with different severities and transfusion requirements.
    Nakavachara P; Weerakulwattana P; Pooliam J; Viprakasit V
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29789. PubMed ID: 35652568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activin-A is elevated in patients with thalassemia major and double heterozygous sickle cell/beta-thalassemia and correlates with markers of hemolysis and bone mineral density.
    Voskaridou E; Ntanasis-Stathopoulos I; Christoulas D; Dimopoulou M; Komninaka V; Repa K; Papatheodorou A; Terpos E
    Ann Hematol; 2019 Jul; 98(7):1583-1592. PubMed ID: 31041514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of low bone mass among adolescents with nontransfusion-dependent hemoglobin E/β-thalassemia and its relationship with anemia severity.
    Nakavachara P; Petchkul J; Jeerawongpanich K; Kiattisakthavee P; Manpayak T; Netsakulnee P; Chaichanwattanakul K; Pooliam J; Srichairatanakool S; Viprakasit V
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28801997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Status of iron metabolism and erythropoietic proliferation in children with various genotypes of thalassemia].
    Mai HR; Li CG; Wang Y; Shi HS; Zhao WL; Chen YS; Chen XW
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Aug; 12(8):602-4. PubMed ID: 20704788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density in beta-thalassemia major and intermedia.
    Karimi M; Ghiam AF; Hashemi A; Alinejad S; Soweid M; Kashef S
    Indian Pediatr; 2007 Jan; 44(1):29-32. PubMed ID: 17277428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum transferrin receptor as a marker of erythropoiesis suppression in patients on chronic transfusion.
    Tancabelic J; Sheth S; Paik M; Piomelli S
    Am J Hematol; 1999 Feb; 60(2):121-5. PubMed ID: 9929103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.
    Huang Y; Lei Y; Liu R; Liu J; Yang G; Xiang Z; Liang Y; Lai Y
    Int J Med Sci; 2019; 16(2):302-310. PubMed ID: 30745811
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone mineral density and calcium metabolism in adolescents with beta-thalassemia major.
    Tantawy AA; El Kholy M; Moustafa T; Elsedfy HH
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():132-5. PubMed ID: 19337166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Mineral Density and Dickkopf-1 in Adolescents with Non-Deletional Hemoglobin H Disease.
    Wiromrat P; Rattanathongkom A; Laoaroon N; Suwannaying K; Komwilaisak P; Panamonta O; Wongsurawat N; Nasomyont N
    J Clin Densitom; 2023; 26(3):101379. PubMed ID: 37147222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between soluble transferrin receptor and serum ferritin levels following bone marrow transplantation for thalassemia.
    Centis F; Delfini C; Agostinelli F; Barbanti I; Annibali M; Lucarelli G
    Eur J Haematol; 1995 May; 54(5):329-33. PubMed ID: 7781757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythroid marrow activity and hemoglobin H levels in hemoglobin H disease.
    Papassotiriou I; Traeger-Synodinos J; Kanavakis E; Karagiorga M; Stamoulakatou A; Kattamis C
    J Pediatr Hematol Oncol; 1998; 20(6):539-44. PubMed ID: 9856674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma neutrophil gelatinase-associated lipocalin levels are markedly increased in patients with non-transfusion-dependent thalassemia: Lack of association with markers of erythropoiesis, iron metabolism and renal function.
    Patsaoura A; Tatsi E; Margeli A; Kanavaki I; Delaporta P; Kyriakopoulou D; Kouraklis-Symeonidis A; Kattamis A; Papassotiriou I
    Clin Biochem; 2014 Aug; 47(12):1060-4. PubMed ID: 24721683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythroid bone marrow activity and red cell hemoglobinization in iron sufficient beta-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin in content. Correlation with genotypes and Hb A(2) levels.
    Skarmoutsou C; Papassotiriou I; Traeger-Synodinos J; Stamou H; Ladis V; Metaxotou-Mavrommati A; Stamoulakatou A; Kanavakis E
    Haematologica; 2003 Jun; 88(6):631-6. PubMed ID: 12801838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.